Previous Section
General Interest Articles
11. Estimated number of cases, regional distribution and survival of patients diagnosed with acute myeloid leukemia between 1996 and 2000 in Rio Grande do Sul, Brazil.
- Author
- Capra M; Vilella L; Pereira WV; Coser VM; Fernandes MS; Schilling MA; Almeida D; Gross M; Leite M; Hellwig T; Natchigal G; Zelmanowicz A; Paskulin G; Neumann J; Silla L;
- Institution
- Division of Hematology and Bone Marrow Transplantation, Hospital de Clinicas de Porto Alegre, Programa de Pos-Graduacao em Clinica medica da Universidade Federal do Rio Grande do Sul. marcelocapra@hotmail.com
- Journal
- Leuk Lymphoma. 2007 Dec;48(12):2381-6.
- Abstract URL
- Click here to view abstract
12. Advances in the biology and therapy of acute myelogenous leukemia. Selection of keynote addresses from the Acute Leukemia Forum 2007. March 23, 2007. San Francisco, California, USA.
- Author
- Institution
- Journal
- Best Pract Res Clin Haematol. 2008 Mar;21(1):1-98.
13. Minimally differentiated acute myeloid leukemia (FAB AML-M0) is associated with an adverse outcome in children: a report from the Children's Oncology Group, studies CCG-2891 and CCG-2961.
- Author
- Barbaric D; Alonzo TA; Gerbing RB; Meshinchi S; Heerema NA; Barnard DR; Lange BJ; Woods WG; Arceci RJ; Smith FO;
- Institution
- Division of Hematology/Oncology/BMT, BC's Children's Hospital, Vancouver, BC, Canada. dragmatt96@optusnet.com.au
- Journal
- Blood. 2007 Mar 15;109(6):2314-21. Epub 2006 Dec 7.
- Abstract URL
- Click here to view abstract
14. Anthracyclines, mitoxantrone, radiotherapy, and granulocyte colony-stimulating factor: risk factors for leukemia and myelodysplastic syndrome after breast cancer.
- Author
- Le Deley MC; Suzan F; Cutuli B; Delaloge S; Shamsaldin A; Linassier C; Clisant S; de Vathaire F; Fenaux P; Hill C; Le Deley MC; Suzan F; Cutuli B; Delaloge S; Shamsaldin A; Linassier C; Clisant S; de Vathaire F; Fenaux P; Hill C;
- Institution
- Biostatistics and Epidemiology Unit, Department of Medicine, , Institut Gustave-Roussy, Villejuif, France. le_deley@igr.fr
- Journal
- J Clin Oncol. 2007 Jan 20;25(3):292-300. Epub 2006 Dec 11.
- Abstract URL
- Click here to view abstract
15. Longitudinal evaluation of early and late anthracycline cardiotoxicity in children with AML.
- Author
- Creutzig U; Diekamp S; Zimmermann M; Reinhardt D;
- Institution
- Department of Pediatric Hematology and Oncology, University Children's Hospital, Muenster, Germany.
- Journal
- Pediatr Blood Cancer. 2007 Jun 15;48(7):651-62.
- Abstract URL
- Click here to view abstract
16. Outcomes in childhood AML in the absence of transplantation in first remission--Children's Cancer Group (CCG) studies 2891 and CCG 213.
- Author
- Castellino SM; Alonzo TA; Buxton A; Gold S; Lange BJ; Woods WG; Castellino SM; Alonzo TA; Buxton A; Gold S; Lange BJ; Woods WG;
- Institution
- ETSU Quillen College of Medicine, Johnson City, Tennessee, USA. scastell@wfubmc.edu
- Journal
- Pediatr Blood Cancer. 2008 Jan;50(1):9-16.
- Abstract URL
- Click here to view abstract
17. Toxicity and outcome of children with treatment related acute myeloid leukemia.
- Author
- Tabori U; Revach G; Nathan PC; Strahm B; Rachlis A; Shago M; Grant R; Doyle J; Malkin D; Tabori U; Revach G; Nathan PC; Strahm B; Rachlis A; Shago M; Grant R; Doyle J; Malkin D;
- Institution
- Departments of Hematology Oncology and Paediatric Laboratory Medicine, The Hospital for Sick Children, Toronto, Canada.
- Journal
- Pediatr Blood Cancer. 2008 Jan;50(1):17-23.
- Abstract URL
- Click here to view abstract
18. Prevention and monitoring of invasive fungal infections in pediatric patients with cancer and hematologic disorders.
- Author
- Hovi L; Saxen H; Saarinen-Pihkala UM; Vettenranta K; Meri T; Richardson M;
- Institution
- Hospital for Children and Adolescents, University of Helsinki, Helsinki, Finland. liisa.hovi@hus.fi
- Journal
- Pediatr Blood Cancer. 2007 Jan;48(1):28-34.
- Abstract URL
- Click here to view abstract
19. Effect of race on outcome of white and black children with acute myeloid leukemia: the St. Jude experience.
- Author
- Rubnitz JE; Lensing S; Razzouk BI; Pounds S; Pui CH; Ribeiro RC;
- Institution
- Department of Hematology-Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA. jeffrey.rubnitz@stjude.org
- Journal
- Pediatr Blood Cancer. 2007 Jan;48(1):10-5.
- Abstract URL
- Click here to view abstract
20. CXCR4 is a prognostic marker in acute myelogenous leukemia.
- Author
- Spoo AC; Lubbert M; Wierda WG; Burger JA;
- Institution
- Department of Medicine, Freiburg University Hospital, Germany.
- Journal
- Blood. 2007 Jan 15;109(2):786-91. Epub 2006 Aug 3.
- Abstract URL
- Click here to view abstract
Next: Drug Therapy
